No results found for "".

Commentary & Deal Flow

PRICED: Neopharmed Gentili EUR890m 7NC1 Sr Sec FRN, E+325 at par

HYC European Market: Deal Flow - General

***Corrected IPT PXD

Issuer

Term

Call

Coupon

Maturity

Size

Ranking

Type

Price

Spread

IPT-PXD

Neopharmed Gentili

7NC1

1y

E+325

29-Jun-33

€890m (up from EUR425m)

Sr Sec

Floating

100

E+325

-50


Reoffer: E+325 / 100

Launched: €890m @ E+325 at par (EUR465m upsize to refinance EUR450m 7.125% sr sec notes due 08-APR-2030 notes)

Price Talk: E+325-350, 0%, par
IPTs: High 3s, par


  • Issuer: Neopharmed Gentili S.p.A.
  • Ticker: NEGENT
  • Corporate Ratings: B3/B/B (Moody's/S&P/Fitch)
  • Issue Ratings: B3/B/B (Moody's/S&P/Fitch)
  • Instrument: Senior Secured Floating Rate Notes
  • Size: €890m (up from EUR425m)
  • Trade Date: 18-Jun-26
  • Settlement: 29-Jun-26 (T+7)
  • Maturity: 29-Jun-33
  • Margin: E+325bps
  • Floor: 0%
  • Issue Price: 100
  • Make-Whole: BUNDS + 50bps
  • Optional Redemption: Commencing 29-Jun-27 – 100%
  • Change of Control: 101
  • Interest Payment Dates: Quarterly on 15-Jan, 15-Apr, 15-Jul, 15-Oct
  • First Interest Payment Date: 15-Oct-26
  • Day Count: ACT / 365
  • Format: 144A/Reg S
  • Denominations: €100k x €1k
  • Listing: Luxembourg Stock Exchange
  • Governing Law: New York
  • ISIN:
    • Reg S: XS3416905365
    • 144A: XS3416905878
  • Sole Global Coordinator and Physical Bookrunner: BNP Paribas (B&D)
  • Joint Bookrunners: Banca Akros, CACIB, GS, IMI, JPM, Natixis
  • UOP: refinance its EUR400m sr sec FRNs due 08-Apr-30 (callable at 100), and fund a EUR23m distribution to its parent to repay a portion of the EUR157m PIK Notes (EUR465m upsize to refinance EUR450m 7.125% sr sec notes due 08-APR-2030 notes)
  • Equity Sponsors: Renaissance Partners (42.1%)/Ardian (42.1%)/Del Bono family (14.4%)
  • Timing:
    • TOE: 11:47 UKT, 18-Jun-26
    • FTT: 16:15 UKT, 18-Jun-26
  • Advertisement: This communication is an advertisement and does not constitute a prospectus for the purposes of Regulation (EU) 2017/1129 and underlying legislation. The Offering Memorandum, when published, will be available on the website of the Luxembourg Stock Exchange at: https://www.luxse.com
  • Target Market: No EU PRIIPs key information document (KID) and no UK disclosure document required by DISC have been prepared as the notes are not available to retail in EEA or UK
  • Marketing:
  • Investor Call: GIC 8:30 UKT / 9:30 CET, 16-June-2026
  • Q&A Sessions: 16/17-June-2026

https://dealroadshow.com/e/NEO2026 (Access Code: NEO2026)

https://evercall.co/oacc/46099 (GIC Registration)